TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27107029

Group type: EXPERIMENTAL
Intervention: Monovision contact lenses (one eye corrected for distance, the other for near vision)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Simultaneous vision (progressive lenses)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Monovision
Number of subjects: 13

Group type: COMPARATOR
Intervention: Simultaneous vision
Number of subjects: 13
Study: 28531467

Group type: EXPERIMENTAL
Intervention: Red wine consumption (once daily for 1 month)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo drink (after a 1 month washout period)
Number of subjects: 40
Study: 24158582

Group type: EXPERIMENTAL
Intervention: Pure PTFE-coated probes
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ceramic-reinforced PTFE-coated probes
Number of subjects: 10

Group type: COMPARATOR
Intervention: Stainless steel (control)
Number of subjects: 10
Study: 20520568

Group type: EXPERIMENTAL
Intervention: Fixed-combination latanoprost/timolol (Xalacom)
Number of subjects: 828
Study: 18573123

Group type: EXPERIMENTAL
Intervention: Cortical bone and bovine hydroxyapatite (HA) grafting on right sinuses
Number of subjects: 5

Group type: COMPARATOR
Intervention: Autologous bone plus bioglass (BG) material grafting on left sinuses
Number of subjects: 5
Study: 17279183

Group type: EXPERIMENTAL
Intervention: Fluoroquinolone therapy
Number of subjects: 0
Study: 14533368

Group type: EXPERIMENTAL
Intervention: Exercise and walking protocol (12-week duration)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 50
Study: 11568690

Group type: EXPERIMENTAL
Intervention: Chymopapain (4000 IU)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Collagenase (400 ABC units)
Number of subjects: 100
Study: 9776797

Group type: EXPERIMENTAL
Intervention: Self-monitoring tool with monthly feedback of phosphorus levels and interdialytic weight gains
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no self-monitoring tool)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Self-monitoring tool
Number of subjects: 40
Study: 7849688

Group type: EXPERIMENTAL
Intervention: Structured interventions consisting of visual, auditory, olfactory, gustatory and tactile stimulation
Number of subjects: 7
Study: 3043077

Group type: EXPERIMENTAL
Intervention: Plasma exchange with corticosteroids, cytotoxic drug, hemodialysis only when needed (Group I)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Peritoneal dialysis with corticosteroids and cytotoxic drug (Group II)
Number of subjects: 29
Study: 1396837

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Flecainide
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 141

Group type: COMPARATOR
Intervention: Overall (Amiodarone, Flecainide, Propafenone)
Number of subjects: 141
Study: 363136

Group type: EXPERIMENTAL
Intervention: ethinyl oestradiol 50 microgram/day
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: norgestrel 250 microgram/day
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Nordiol (combination of ethinyl oestradiol and norgestrel)
Number of subjects: 49

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 49
Study: 31931927

Group type: EXPERIMENTAL
Intervention: Butyphthalide combined with idebenone
Number of subjects: 88

Group type: COMPARATOR
Intervention: Idebenone
Number of subjects: 88
Study: 30241872

Group type: EXPERIMENTAL
Intervention: Participants who did not receive information about their medications
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Participants who did not regularly visit a primary health-care provider
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Participants who had changes in their treatment
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Participants who reported using pillboxes
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Participants who had help from a caregiver
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Participants who integrated medication dosing into daily routines
Number of subjects: 150
Study: 28619692

Group type: EXPERIMENTAL
Intervention: Teen Options to Prevent Pregnancy intervention
Number of subjects: 598

Group type: COMPARATOR
Intervention: Usual-care control condition
Number of subjects: 598
Study: 27231800

Group type: EXPERIMENTAL
Intervention: Medication reconciliation (intervention group)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Standard practice (control group)
Number of subjects: 147
Study: 25093754

Group type: EXPERIMENTAL
Intervention: Monthly dihydroartemisinin‐piperaquine (DP)
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Daily trimethoprim‐sulfamethoxazole (TS)
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Monthly sulfadoxine‐pyrimethamine (SP)
Number of subjects: 393

Group type: COMPARATOR
Intervention: No chemoprevention
Number of subjects: 393
Study: 22502956

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 1195

Group type: EXPERIMENTAL
Intervention: Hypnotherapy
Number of subjects: 1195

Group type: EXPERIMENTAL
Intervention: Aversive smoking
Number of subjects: 1195
Study: 19068274

Group type: EXPERIMENTAL
Intervention: Intermittent FOLFIRI chemotherapy
Number of subjects: 266

Group type: COMPARATOR
Intervention: Continuous FOLFIRI chemotherapy
Number of subjects: 266
Study: 17321427

Group type: EXPERIMENTAL
Intervention: Intervention with parental support
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 15
Study: 15362330

Group type: EXPERIMENTAL
Intervention: Cognitive skills training with fewer task repetitions (3 or 4)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Technical skills training with more task repetitions (5 or 6)
Number of subjects: 21
Study: 12213435

Group type: EXPERIMENTAL
Intervention: Beraprost sodium for at least 12 months
Number of subjects: 17
Study: 9835004

Group type: EXPERIMENTAL
Intervention: High-dose aprotinin (mean 5.2 x 10(6) KIU)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Low-dose aprotinin (2 x 10(6) KIU)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group without aprotinin
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: All patients (including both aprotinin doses)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Aprotinin-treated patients (both doses)
Number of subjects: 35
Study: 7730602

Group type: EXPERIMENTAL
Intervention: Modern Balinese Baris Dancing Exercise (MBBDE)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 60
Study: 2521409

Group type: EXPERIMENTAL
Intervention: Orthoclone OKT3 for 14 days, azathioprine, and steroids
Number of subjects: 52

Group type: COMPARATOR
Intervention: Cyclosporine, azathioprine, and steroids
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Orthoclone OKT3 for 14 days
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Orthoclone OKT3
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: OKT3
Number of subjects: 52

Group type: COMPARATOR
Intervention: Orthoclone OKT3 and Cyclosporine
Number of subjects: 52
Study: 1080382

Group type: EXPERIMENTAL
Intervention: Phenylbutazone-prednisone combination
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 4
Study: 31172175

Group type: EXPERIMENTAL
Intervention: 8 kcal/kg of body weight/wk
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: 20 kcal/kg of body weight/wk
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 198
Study: 29911777

Group type: EXPERIMENTAL
Intervention: 0.1% Tretinoin Cream
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Herbal Extract Cream
Number of subjects: 48
Study: 25785703

Group type: EXPERIMENTAL
Intervention: 6% Carbohydrate (CHO) solution (15 g; 0.20 ± 0.02 g·kg(‐1))
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 1.2% Caffeine (CAF) solution (300 mg; 3.9 ± 0.3 mg·kg(‐1))
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Carbohydrate with caffeine (C + C) solution
Number of subjects: 15

Group type: COMPARATOR
Intervention: Water (placebo; PLA)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (no solution rinsed)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: All trials
Number of subjects: 15
Study: 23480456

Group type: COMPARATOR
Intervention: M (PCA regimen with morphine)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: TM (PCA regimen with tenoxicam and morphine)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: T+TM (20 mg tenoxicam administered 30 minutes before wound closure in addition to the TM regimen)
Number of subjects: 94
Study: 21619984

Group type: EXPERIMENTAL
Intervention: Troponin I measurements at various time points (T6, T12, T24, T48, T72) and cumulative area under the curve (CAUC24, CAUC48, CAUC72)
Number of subjects: 440
Study: 19334078

Group type: EXPERIMENTAL
Intervention: Lumbar sympathetic block (LSB) with bupivacaine and botulinum toxin A (BTA)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Standard lumbar sympathetic block (LSB) with bupivacaine
Number of subjects: 9
Study: 16633144

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 394

Group type: COMPARATOR
Intervention: Ziprasidone
Number of subjects: 394
Study: 15223872

Group type: EXPERIMENTAL
Intervention: Chronic cough patients
Number of subjects: 50

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 50
Study: 10688810

Group type: EXPERIMENTAL
Intervention: Cs‐A1 (1 mg/kg/d)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Cs‐A3 (3 mg/kg/d)
Number of subjects: 59
Study: 9093631

Group type: EXPERIMENTAL
Intervention: Halofantrine (HF)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (S-P)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Chloroquine (CQ)
Number of subjects: 110
Study: 1353088

Group type: EXPERIMENTAL
Intervention: Topical antiseptics (alcohol wipes and hexachlorophane powder)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment (untreated with topical antiseptics)
Number of subjects: 0
Study: 3922070

Group type: EXPERIMENTAL
Intervention: 20 per cent lipid solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fat solutions alone or in combination with isotonic concentrations of dextrose
Number of subjects: 0
Study: 30659398

Group type: EXPERIMENTAL
Intervention: Preoperative groin pain (P)
Number of subjects: 309

Group type: COMPARATOR
Intervention: No preoperative pain (N)
Number of subjects: 309
Study: 29465444

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 24
Study: 28642552

Group type: EXPERIMENTAL
Intervention: Aluminium chloride
Number of subjects: 120

Group type: COMPARATOR
Intervention: Epinephrine impregnated gauze
Number of subjects: 120
Study: 26122686

Group type: EXPERIMENTAL
Intervention: Robot-assisted therapy + home exercise program
Number of subjects: 99

Group type: COMPARATOR
Intervention: Home exercise program
Number of subjects: 99
Study: 24114693

Group type: EXPERIMENTAL
Intervention: Fixed-time schedule of brief breaks (noncontingent escape) from ongoing dental treatment
Number of subjects: 151

Group type: COMPARATOR
Intervention: Usual behavior management
Number of subjects: 151
Study: 21079764

Group type: EXPERIMENTAL
Intervention: Passive viewing of global structure
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Horizontal Glass patterns
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Radial and rotational Glass patterns
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Visual area V3a
Number of subjects: 8

Group type: COMPARATOR
Intervention: Visual area V1
Number of subjects: 8
Study: 18430652

Group type: EXPERIMENTAL
Intervention: Left atrial surgical radiofrequency ablation
Number of subjects: 357
Study: 16837929

Group type: EXPERIMENTAL
Intervention: High flow nasal cannula CPAP
Number of subjects: 40

Group type: COMPARATOR
Intervention: Infant Flow Nasal CPAP
Number of subjects: 40
Study: 12946763

Group type: EXPERIMENTAL
Intervention: Levofloxacin 500 mg once daily for 28 days
Number of subjects: 377

Group type: COMPARATOR
Intervention: Ciprofloxacin 500 mg twice daily for 28 days
Number of subjects: 377
Study: 10400480

Group type: EXPERIMENTAL
Intervention: Azelastine nasal spray (2 sprays per nostril bid, 1.1 mg/day)
Number of subjects: 1070

Group type: COMPARATOR
Intervention: Combination therapy with loratadine (10 mg/day) and beclomethasone (2 sprays per nostril bid, 336 microg/day)
Number of subjects: 1070
Study: 8723848

Group type: EXPERIMENTAL
Intervention: Ketorolac 60 mg, administered intramuscularly 30 minutes before surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (placebo), administered intramuscularly 30 minutes before surgery
Number of subjects: 60
Study: 1878075

Group type: EXPERIMENTAL
Intervention: Alcoholic beverages (40 g alcohol) in the form of beer, red wine, or spirits
Number of subjects: 8

Group type: COMPARATOR
Intervention: Mineral water (control)
Number of subjects: 8
Study: 7470395

Group type: EXPERIMENTAL
Intervention: British Comparative Thromboplastin (BCT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amidolytic assays for factors II and X
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chromogenic substrate assays
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Factor II and X amidolytic methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Specific amidolytic assay for factor VII
Number of subjects: 0
Study: 31675390

Group type: EXPERIMENTAL
Intervention: Nurse-delivered collaborative care for depression
Number of subjects: 301

Group type: COMPARATOR
Intervention: Usual care by physician
Number of subjects: 301
Study: 31055192

Group type: EXPERIMENTAL
Intervention: BioFreedom drug-coated stent
Number of subjects: 3150

Group type: COMPARATOR
Intervention: Orsiro biodegradable polymer stent
Number of subjects: 3150
Study: 28245700

Group type: EXPERIMENTAL
Intervention: Home-based video teleconferencing
Number of subjects: 22

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 22
Study: 25940684

Group type: EXPERIMENTAL
Intervention: Upper limb training protocols (90 to 120 minutes of intervention every weekday for 3 to 4 weeks)
Number of subjects: 95
Study: 23751277

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Fluvastatin 20 mg/day
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 21281870

Group type: EXPERIMENTAL
Intervention: omalizumab
Number of subjects: 65

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 65
Study: 19448327

Group type: EXPERIMENTAL
Intervention: Nocturnal oxygen therapy (HOT)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Usual breathing (control)
Number of subjects: 51
Study: 16829499

Group type: EXPERIMENTAL
Intervention: Flicking-off with a plastic instrument 3 min after initial polymerization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wiping action with cotton pellets
Number of subjects: 0
Study: 14601712

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 10676602

Group type: EXPERIMENTAL
Intervention: Amlodipine (10 mg once daily)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Enalapril (20 mg once daily)
Number of subjects: 50
Study: 8476721

Group type: EXPERIMENTAL
Intervention: 1,25-dihydroxyvitamin D3
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: dihydrotachysterol
Number of subjects: 0
Study: 2869772

Group type: EXPERIMENTAL
Intervention: Temazepam 40 mg by mouth (as soft gelatin capsules) followed at 35 min by i.v. saline
Number of subjects: 39

Group type: COMPARATOR
Intervention: Oral placebo followed at 35 min by i.v. diazepam 10 mg (Diazemuls)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Temazepam 40 mg by mouth (as soft gelatin capsules)
Number of subjects: 39
Study: 30371148

Group type: EXPERIMENTAL
Intervention: MDMA 125 mg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: MDMA 100 mg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: MDMA 40 mg (low dose)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: MDMA (all active doses)
Number of subjects: 28
Study: 27150317

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (1 mA, 10 min)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (1 mA, 10 min)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham tDCS (1 mA, 10 min)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: All tDCS conditions (anodal, cathodal, sham)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Group level analysis of tDCS effects
Number of subjects: 14
Study: 24970869

Group type: EXPERIMENTAL
Intervention: Paricalcitol (1 μg/d)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Calcitriol (0.25 μg/d)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 110
Study: 22801093

Group type: EXPERIMENTAL
Intervention: Cotrimoxazole Prophylactic Treatment (CPT)
Number of subjects: 0
Study: 20482348

Group type: EXPERIMENTAL
Intervention: Combination headgear (HG)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 99
Study: 18688081

Group type: EXPERIMENTAL
Intervention: CYP3A5 3 allele
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: CYP3A4 1B allele
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: MDR1 T allele
Number of subjects: 317
Study: 15735111

Group type: EXPERIMENTAL
Intervention: Daily multiple micronutrient (DMM) supplementation
Number of subjects: 306

Group type: COMPARATOR
Intervention: Daily placebo (P) supplementation
Number of subjects: 306

Group type: COMPARATOR
Intervention: Weekly multiple micronutrient (WMM) supplementation
Number of subjects: 306

Group type: COMPARATOR
Intervention: Daily iron (DI) supplementation
Number of subjects: 306
Study: 12057733

Group type: EXPERIMENTAL
Intervention: GnRHa (3.75 mg/4 weeks of triptorelin or 3.6 mg/4 weeks of goserelin)
Number of subjects: 32

Group type: COMPARATOR
Intervention: No GnRHa
Number of subjects: 32
Study: 10342616

Group type: EXPERIMENTAL
Intervention: Squeezable feeding bottle (assisted feeding)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Rigid feeding bottle
Number of subjects: 101
Study: 8962906

Group type: EXPERIMENTAL
Intervention: Group A (severe chronic hepatitis)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Group B (mild/moderate chronic hepatitis)
Number of subjects: 36
Study: 1430613

Group type: EXPERIMENTAL
Intervention: Treated phobics
Number of subjects: 38

Group type: COMPARATOR
Intervention: Untreated phobics
Number of subjects: 38
Study: 6377563

Group type: EXPERIMENTAL
Intervention: Dihomo-gamma-linolenic acid (DHLA) 1.0 g daily for 4 weeks
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 31326135

Group type: EXPERIMENTAL
Intervention: Partial Knee Replacement (PKR)
Number of subjects: 528

Group type: COMPARATOR
Intervention: Total Knee Replacement (TKR)
Number of subjects: 528
Study: 30315178

Group type: EXPERIMENTAL
Intervention: Overweight children (OW)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Healthy weight children (HW)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Percent fat
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: CRP
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: TNFα
Number of subjects: 71
Study: 26024672

Group type: EXPERIMENTAL
Intervention: School-based smoking prevention program (Eigenständig werden 5+6)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Normative expectations concerning peer smoking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resistance skill of saying 'no'
Number of subjects: 0
Study: 24783961

Group type: EXPERIMENTAL
Intervention: EB4K with Play intervention
Number of subjects: 844

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 844
Study: 22885561

Group type: EXPERIMENTAL
Intervention: Moderate to high soy genistein intake
Number of subjects: 300

Group type: COMPARATOR
Intervention: Little or no soy genistein intake
Number of subjects: 300
Study: 19656436

Group type: EXPERIMENTAL
Intervention: 16-week trial lifestyle intervention
Number of subjects: 55
Study: 18823196

Group type: EXPERIMENTAL
Intervention: High perceptual load in a letter-search task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low perceptual load in a letter-search task
Number of subjects: 0
Study: 15716202

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg po qhs for at least 4 weeks
Number of subjects: 98
Study: 11834123

Group type: EXPERIMENTAL
Intervention: High-dose glutamine (0.3 g x kg(‐1))
Number of subjects: 6

Group type: COMPARATOR
Intervention: Glycine (0.3 g x kg(‐1))
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (calorie-free fruit juice only)
Number of subjects: 6
Study: 10320226

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (n = 6)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline (Control group, n = 6)
Number of subjects: 12
Study: 7720759

Group type: COMPARATOR
Intervention: felodipine 10 mg (single dose)
Number of subjects: 12

Group type: COMPARATOR
Intervention: HCTZ 12.5 mg (single dose)
Number of subjects: 12

Group type: COMPARATOR
Intervention: felodipine 10 mg b.i.d. (steady-state)
Number of subjects: 12

Group type: COMPARATOR
Intervention: HCTZ 12.5 mg b.i.d. (steady-state)
Number of subjects: 12

Group type: COMPARATOR
Intervention: felodipine (any dose)
Number of subjects: 12

Group type: COMPARATOR
Intervention: HCTZ (any dose)
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 1462915

Group type: EXPERIMENTAL
Intervention: Double-balloon technique (group A)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Inoue single-balloon technique (group B)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (group A)
Number of subjects: 45
Study: 6581062

Group type: EXPERIMENTAL
Intervention: Fenoterol inhalation powder
Number of subjects: 9

Group type: COMPARATOR
Intervention: Fenoterol metered dose inhaler
Number of subjects: 9
Study: 31732876

Group type: EXPERIMENTAL
Intervention: ECOG score 0
Number of subjects: 3143

Group type: COMPARATOR
Intervention: ECOG score 1
Number of subjects: 3143
Study: 30116855

Group type: EXPERIMENTAL
Intervention: Non-steroidal anti-inflammatory drugs (NSAIDs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weak and strong opioids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-opioid medications (e.g., paracetamol, metamizole)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26903582

Group type: EXPERIMENTAL
Intervention: Intra-arterial treatment (IAT) with retrievable stents
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intra-arterial treatment (Control)
Number of subjects: 0